Sassi Nir 4
4 · Indaptus Therapeutics, Inc. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-25+60,000→ 60,000 totalExercise: $4.18Exp: 2032-02-25→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on February 25, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.